Marker Therapeutics (MRKR) FY Conference Transcript

Marker Therapeutics (MRKR) FY Conference August 12, 2025 12:30 PM ET Speaker0Alright. Good afternoon. I'm John Newman, one of the senior biotech analysts at Canaccord Genuity. Thank you for joining us at the forty fifth annual Canaccord Genuity growth conference. We're very excited to have, Marker with us today.We have the CEO, doctor Juan Vera. So, Juan, welcome. Thank you. Very excited to have you with us today. So I'm wondering if you could start by talking about Marker's MarT cell approach and what make ...